Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
*Kaempferia galanga*, commonly known as aromatic ginger or kencur, is a perennial herb in the Zingiberaceae family native to Southeast Asia and Southern China. It is extensively utilized in traditional medicine systems, including Ayurveda and Traditional Chinese Medicine, for the treatment of inflammatory conditions, pain, and digestive disorders. The plant's pharmacological profile is largely attributed to its essential oil and specific chemical constituents, most notably ethyl p-methoxycinnamate (EPMC) and ethyl cinnamate. EPMC has been shown to possess potent anti-inflammatory activity by inhibiting the cyclooxygenase-2 (COX-2) enzyme and suppressing the NF-kappaB signaling pathway. Additionally, the extract exhibits vasorelaxant, antimicrobial, and antioxidant properties. While widely available as a dietary supplement and culinary ingredient, it is not currently approved as a pharmaceutical drug by major regulatory agencies like the FDA.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on kaempferia galanga.